|
| 36816757 | Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease. | Mol Ther Methods Clin Dev | 2023 |
| 36816757 | Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease. | Mol Ther Methods Clin Dev | 2023 |
| 37256121 | Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective. | Front Immunol | 2023 |
| 37256121 | Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective. | Front Immunol | 2023 |
| 35298086 | Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disorders. | EMBO Mol Med | 2022 |
| 35878742 | Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria. | Transplant Cell Ther | 2022 |
| 35298086 | Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disorders. | EMBO Mol Med | 2022 |
| 35878742 | Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria. | Transplant Cell Ther | 2022 |
| 33633114 | Lentivirus-mediated gene therapy for Fabry disease. | Nat Commun | 2021 |
| 33633114 | Lentivirus-mediated gene therapy for Fabry disease. | Nat Commun | 2021 |
| 31493539 | Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases. | Biol Blood Marrow Transplant | 2020 |
| 32105293 | Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial. | JAMA Oncol | 2020 |
| 32275165 | <sup>90</sup>Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma. | Cancer Biother Radiopharm | 2020 |
| 31493539 | Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases. | Biol Blood Marrow Transplant | 2020 |
| 32105293 | Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial. | JAMA Oncol | 2020 |
| 32275165 | <sup>90</sup>Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma. | Cancer Biother Radiopharm | 2020 |
| 30362577 | Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence. | Transfusion | 2019 |
| 34595426 | Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus Instrument. | Clin Hematol Int | 2019 |
| 30362577 | Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence. | Transfusion | 2019 |
| 30342913 | Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution. | Biol Blood Marrow Transplant | 2019 |
| 30089900 | Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients. | Bone Marrow Transplant | 2019 |
| 34595426 | Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus Instrument. | Clin Hematol Int | 2019 |
| 30089900 | Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients. | Bone Marrow Transplant | 2019 |
| 30342913 | Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution. | Biol Blood Marrow Transplant | 2019 |
| 30115712 | Wandering spleen caused by subcapsular haemorrhage. | BMJ Case Rep | 2018 |
| 30115712 | Wandering spleen caused by subcapsular haemorrhage. | BMJ Case Rep | 2018 |
| 30054205 | PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. | Immunity | 2018 |
| 30054205 | PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. | Immunity | 2018 |
| 27713092 | The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. | Biol Blood Marrow Transplant | 2017 |
| 28490441 | PD-1 regulates KLRG1<sup>+</sup> group 2 innate lymphoid cells. | J Exp Med | 2017 |
| 28797782 | Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients. | Biol Blood Marrow Transplant | 2017 |
| 28473623 | Tbet is a critical modulator of FoxP3 expression in autoimmune graft-<i>versus</i>-host disease. | Haematologica | 2017 |
| 27713092 | The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. | Biol Blood Marrow Transplant | 2017 |
| 28473623 | Tbet is a critical modulator of FoxP3 expression in autoimmune graft-<i>versus</i>-host disease. | Haematologica | 2017 |
| 28490441 | PD-1 regulates KLRG1<sup>+</sup> group 2 innate lymphoid cells. | J Exp Med | 2017 |
| 28797782 | Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients. | Biol Blood Marrow Transplant | 2017 |
| 26811520 | Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease. | J Clin Oncol | 2016 |
| 26811520 | Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease. | J Clin Oncol | 2016 |
| 26981558 | T memory stem cell formation: Caveat mTOR. | EBioMedicine | 2016 |
| 27694491 | Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease. | J Immunol | 2016 |
| 28157677 | IL-27: a new target for GVHD prevention. | Blood | 2016 |
| 28157677 | IL-27: a new target for GVHD prevention. | Blood | 2016 |
| 27694491 | Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease. | J Immunol | 2016 |
| 26981558 | T memory stem cell formation: Caveat mTOR. | EBioMedicine | 2016 |
| 25532725 | Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo. | Stem Cells | 2015 |
| 25532725 | Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo. | Stem Cells | 2015 |
| 26088932 | Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice. | Haematologica | 2015 |
| 26130705 | Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. | Blood | 2015 |
| 25992859 | Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps. | Immunity | 2015 |
| 26113534 | Syk and tired of current chronic GVHD therapies. | Blood | 2015 |